Safety and Efficacy of 1.5 mg/kg Once Daily Bridging Dosing Regimen as Compared to 1 mg/kg Twice Daily Dosing Regimen as Measured by 7 and 30 Day Outcomes

被引：0
|
作者：
Kondrack, Robyn
机构：
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2010年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected Children
    Bastiaans, Diane E. T.
    Geelen, Sibyl P. M.
    Visser, Eline G.
    van der Flier, Michiel
    Vermont, Clementien L.
    Colbers, Angela P. H.
    Roukens, Monique
    Burger, David M.
    van Rossum, Annemarie M. C.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 1008 - 1010
  • [22] Efficacy, tolerability and safety of once-monthly administration of 75 mg risedronate in Japanese patients with involutional osteoporosis: A comparison with a 2.5 mg once-daily dosage regimen
    Hagino, Hiroshi
    Kishimoto, Hideaki
    Ohishi, Hiroaki
    Horii, Sayako
    Nakamura, Toshitaka
    BONE, 2014, 59 : 44 - 52
  • [23] A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks
    Gathe, Joseph
    da Silva, Barbara A.
    Cohen, Daniel E.
    Loutfy, Mona R.
    Podzamczer, Daniel
    Rubio, Rafael
    Gibbs, Sara
    Marsh, Theresa
    Naylor, Christian
    Fredrick, Linda
    Bernstein, Barry
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (05) : 474 - 481
  • [24] The efficacy and safety of lansoprazole (LAN) 30mg once daily vs cisapride (CIS) 20 mg twice daily for 8 weeks in the acute treatment of erosive reflux oesophagitis (ERO).
    van Rensburg, CJ
    Schmidt, SJ
    Moola, SA
    GASTROENTEROLOGY, 2000, 118 (04) : A1318 - A1318
  • [25] Altering the Time of Day of Once-Daily Dosing of Insulin Degludec Achieves Similar Glycemic Control and Safety Compared to Dosing the Same Time of Day in People With Type 1 Diabetes
    Russell-Jones, David L.
    Hollander, Priscilla
    Miranda-Palma, Bresta
    Cooper, John G.
    Franek, Edward
    Bain, Stephen
    Djurhuus, Christian B.
    Tamer, Soren C.
    Mathieu, Chantal
    DIABETES, 2012, 61 : A91 - A91
  • [26] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN (20 MG ONCE DAILY) COMPARED TO LANSOPRAZOLE (30 MG ONCE-DAILY) IN PATIENTS WITH EROSIVE ESOPHAGITIS (EE)
    Chen, Minhu
    Chun, Hoon Jai
    Sheu, Bor-Shyang
    Chong, Chui Fung
    Funao, Nobuo
    Zhou, Wen
    Goh, Khean Lee
    GASTROENTEROLOGY, 2018, 154 (06) : S237 - S237
  • [27] Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine
    Ashina, Messoud
    Tepper, Stewart
    Reuter, Uwe
    Blumenfeld, Andrew
    Hutchinson, Susan
    Xia, Jing
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel
    NEUROLOGY, 2021, 96 (15)
  • [28] Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine
    Ashina, M.
    Tepper, S. J.
    Reuter, U.
    Blumenfeld, A. M.
    Hutchinson, S.
    Xia, J.
    Miceli, R.
    Severt, L.
    Finnegan, M.
    Trugman, J. M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 46 - 46
  • [29] Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia
    Tamiru, Aschalew
    Mohammed, Rezika
    Atnafu, Saba
    Medhin, Girmay
    Hailu, Asrat
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (08):
  • [30] The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data
    Gu, Jie-mei
    Wang, Li
    Lin, Hua
    Chen, De-cai
    Tang, Hai
    Jin, Xiao-lan
    Xia, Wei-bo
    Hu, Yun-qiu
    Fu, Wen-zhen
    He, Jin-wei
    Zhang, Hao
    Wang, Chun
    Yue, Hua
    Hu, Wei-wei
    Liu, Yu-juan
    Zhang, Zhen-lin
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (07) : 841 - 846
12345